All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99
Paper Submission

Why Us? >>
- Open Access
- Peer-reviewed
- Rapid publication
- Lifetime hosting
- Free indexing service
- Free promotion service
- More...
- Search engine friendly

Blood and Lymphatic Cancer: Targets and Therapy

ISSN Print: 1179-9889

ISSN Online:

Website: https://www.dovepress.com/blood-and-lymphatic-cancer-targets-and-therapy-journal

Share:




Go

Ruxolitinib as an emerging treatment in myelofibrosis

Emanuel RM, Geyer HL, Mesa RA

Novel conditioning regimens for bone marrow transplantation

Shi M, Li M, Ikehara S

Daratumumab improves the anti-myeloma effect of newly emerging multidrug therapies

Gopalakrishnan S,Tan D

MicroRNA dysregulation in B-cell non-Hodgkin lymphoma

Lim EL,Marra MA

Ruxolitinib as an emerging treatment in myelofibrosis

Emanuel RM,Geyer HL,Mesa RA

Novel conditioning regimens for bone marrow transplantation

Shi M,Li M,Ikehara S

The evaluation and optimal use of rituximab in lymphoid malignancies

Robak T, Robak P, Smolewski P

First-line therapy of chronic myeloid leukemia – focus on dasatinib

Amrein PC

Recent developments in myelofibrosis

Tibes R, Bogenberger JM, Mesa RA

Emerging treatment approaches in acute lymphoblastic and acute myeloid leukemias

Thomas X

Advances in the diagnosis and management of lymphoma

Word ZH, Matasar MJ

Peripheral T cell lymphoma: clinical utility of romidepsin

Zain J, Sawey K

Trends in the treatment of cutaneous T-cell lymphoma – critical evaluation and perspectives on vorinostat

Rangwala S, Duvic M, Zhang CL

Profile of brentuximab vedotin and its potential in the treatment of relapsed or refractory Hodgkin lymphoma

Mayes S, Gibb A, Illidge T

Therapeutic developments in acute lymphoblastic leukemia

MacKenzie A, Kasner M

Pharmacology and clinical potential of oblimersen sodium in the treatment of chronic lymphocytic leukemia

Borthakur G, O'Brien S

Role of L-asparaginase in acute lymphoblastic leukemia: focus on adult patients

Rytting ME

Treatment strategies for patients with diffuse large B-cell lymphoma: past, present, and future

Sinha R, Nastoupil LJ, Flowers CR

Profile of brentuximab vedotin and its potential in the treatment of relapsed or refractory Hodgkin lymphoma

Mayes S,Gibb A,Illidge T

Treatment strategies for patients with diffuse large B-cell lymphoma: past, present, and future

Sinha R,Nastoupil LJ,Flowers CR

Therapeutic developments in acute lymphoblastic leukemia

MacKenzie A,Kasner M

Pharmacology and clinical potential of oblimersen sodium in the treatment of chronic lymphocytic leukemia

Borthakur G,O'Brien S

Advances in the diagnosis and management of lymphoma

Word ZH,Matasar MJ

The evaluation and optimal use of rituximab in lymphoid malignancies

Robak T,Robak P,Smolewski P

First-line therapy of chronic myeloid leukemia – focus on dasatinib

Amrein PC

Emerging treatment approaches in acute lymphoblastic and acute myeloid leukemias

Thomas X

Peripheral T cell lymphoma: clinical utility of romidepsin

Zain J,Sawey K

Role of L-asparaginase in acute lymphoblastic leukemia: focus on adult patients

Rytting ME

Recent developments in myelofibrosis

Tibes R,Bogenberger JM,Mesa RA

Trends in the treatment of cutaneous T-cell lymphoma – critical evaluation and perspectives on vorinostat

Rangwala S,Duvic M,Zhang CL

Reduced intensity treatment in early-stage Hodgkin’s lymphoma

Prodduturi P, Armitage JO

mTOR inhibitor in the treatment of Hodgkin’s lymphoma: a case report

Ibeas P, Cantos B, Provencio M.

Mantle cell leukemia as a cause of leukostasis

Smith D, Cable C, Chisholm C, Linz W, Koss W, Dobin S, Rappaport E

Leptomeningeal myelomatosis in previously treated high-risk kappa light chain multiple myeloma: case report and literature review

Ohanian M, Alaly J, Samuel S, Cable C, Halka K

A new era in blood and lymphatic cancer biology and therapy

David Dingli

Reduced intensity treatment in early-stage Hodgkin’s lymphoma

Prodduturi P,Armitage JO

mTOR inhibitor in the treatment of Hodgkin’s lymphoma: a case report

Ibeas P,Cantos B,Provencio M.

Leptomeningeal myelomatosis in previously treated high-risk kappa light chain multiple myeloma: case report and literature review

Ohanian M,Alaly J,Samuel S,Cable C

Mantle cell leukemia as a cause of leukostasis

Smith D,Cable C,Chisholm C,Linz W

A new era in blood and lymphatic cancer biology and therapy

David Dingli

Go




©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705